Minimum effective volume of ropivacaine for ultrasound-guided adductor canal + IPACK block in total knee arthroplasty: A double-blind, randomized dose-finding trial.

IF 1.3 4区 医学 Q3 ORTHOPEDICS
Qiuru Wang, Ting Ma, Jian Hu, Jing Yang, Pengde Kang
{"title":"Minimum effective volume of ropivacaine for ultrasound-guided adductor canal + IPACK block in total knee arthroplasty: A double-blind, randomized dose-finding trial.","authors":"Qiuru Wang,&nbsp;Ting Ma,&nbsp;Jian Hu,&nbsp;Jing Yang,&nbsp;Pengde Kang","doi":"10.1177/10225536231161873","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Our previous study reported that when a respective 20 mL of ropivacaine was used for adductor canal block (ACB) combined with infiltration between the popliteal artery and capsule of the posterior knee (IPACK) block for patients undergoing total knee arthroplasty (TKA), the minimum concentration of 0.275% could provide successful block in almost all patients. Based on the results, the primary objective of this study was to investigate the minimum effective volume (MEV<sub>90</sub>, defined as the volume which can provide successful block in 90% of patients) of ACB + IPACK block.</p><p><strong>Methods: </strong>This double-blind, randomized dose-finding trial was based on a biased coin up-and-down sequential design, where the volume of ropivacaine administered to a given patient depended on the previous patient's response. The first patient received 15 mL of 0.275% ropivacaine for ACB and again for IPACK. If the block failed, the next subject received a 1 mL higher volume for ACB and IPACK, respectively; otherwise, the next subject received either a 1 mL lower volume (probability of 0.11) or the same volume (probability of 0.89). The primary outcome was whether the block was successful. Block success was defined as the patient did not suffer significant pain and did not receive rescue analgesia within 6 h after surgery. Then the MEV<sub>90</sub> was estimated by isotonic regression.</p><p><strong>Results: </strong>Based on analysis of 53 patients, the MEV<sub>90</sub> was 17.99 mL (95% CI 17.47-18.61 mL), MEV<sub>95</sub> was 18.48 mL (95% CI 17.45-18.98 mL) and MEV<sub>99</sub> was 18.90 mL (95% CI 17.38-19.07 mL). Patients whose blocks succeeded had significantly lower NRS pain scores, lower morphine consumption, and shorter hospitalization.</p><p><strong>Conclusion: </strong>0.275% ropivacaine in 17.99 mL respectively can provide successful ACB + IPACK block in 90% of patients undergoing TKA. The minimum effective volume (MEV<sub>90</sub>) of ACB + IPACK block was 17.99 mL.</p>","PeriodicalId":48794,"journal":{"name":"Journal of Orthopaedic Surgery","volume":"31 1","pages":"10225536231161873"},"PeriodicalIF":1.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10225536231161873","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Our previous study reported that when a respective 20 mL of ropivacaine was used for adductor canal block (ACB) combined with infiltration between the popliteal artery and capsule of the posterior knee (IPACK) block for patients undergoing total knee arthroplasty (TKA), the minimum concentration of 0.275% could provide successful block in almost all patients. Based on the results, the primary objective of this study was to investigate the minimum effective volume (MEV90, defined as the volume which can provide successful block in 90% of patients) of ACB + IPACK block.

Methods: This double-blind, randomized dose-finding trial was based on a biased coin up-and-down sequential design, where the volume of ropivacaine administered to a given patient depended on the previous patient's response. The first patient received 15 mL of 0.275% ropivacaine for ACB and again for IPACK. If the block failed, the next subject received a 1 mL higher volume for ACB and IPACK, respectively; otherwise, the next subject received either a 1 mL lower volume (probability of 0.11) or the same volume (probability of 0.89). The primary outcome was whether the block was successful. Block success was defined as the patient did not suffer significant pain and did not receive rescue analgesia within 6 h after surgery. Then the MEV90 was estimated by isotonic regression.

Results: Based on analysis of 53 patients, the MEV90 was 17.99 mL (95% CI 17.47-18.61 mL), MEV95 was 18.48 mL (95% CI 17.45-18.98 mL) and MEV99 was 18.90 mL (95% CI 17.38-19.07 mL). Patients whose blocks succeeded had significantly lower NRS pain scores, lower morphine consumption, and shorter hospitalization.

Conclusion: 0.275% ropivacaine in 17.99 mL respectively can provide successful ACB + IPACK block in 90% of patients undergoing TKA. The minimum effective volume (MEV90) of ACB + IPACK block was 17.99 mL.

超声引导内收管+ IPACK阻滞全膝关节置换术中罗哌卡因的最小有效容积:一项双盲、随机剂量发现试验。
背景:我们之前的研究报道,在全膝关节置换术(TKA)患者中,分别使用20ml罗哌卡因进行内收管阻滞(ACB)联合腘动脉与后膝关节囊间浸润(IPACK)阻滞时,0.275%的最低浓度几乎可以为所有患者提供成功的阻滞。基于上述结果,本研究的主要目的是探讨ACB + IPACK阻滞的最小有效容积(MEV90,定义为90%患者能够成功阻滞的容积)。方法:这项双盲、随机剂量发现试验基于有偏硬币上下顺序设计,其中给予给定患者的罗哌卡因量取决于先前患者的反应。第一例患者接受15 mL 0.275%罗哌卡因用于ACB,再次接受15 mL用于IPACK。如果阻断失败,下一位受试者分别增加1ml ACB和IPACK的量;否则,下一名受试者接受较少1 mL(概率为0.11)或相同体积(概率为0.89)的注射。主要的结果是封锁是否成功。阻滞成功的定义是患者在术后6小时内没有出现明显的疼痛,也没有接受抢救性镇痛。然后用等渗回归估计MEV90。结果:53例患者MEV90为17.99 mL (95% CI 17.47 ~ 18.61 mL), MEV95为18.48 mL (95% CI 17.45 ~ 18.98 mL), MEV99为18.90 mL (95% CI 17.38 ~ 19.07 mL)。阻滞成功的患者NRS疼痛评分显著降低,吗啡用量降低,住院时间缩短。结论:0.275%罗哌卡因17.99 mL可成功阻断90% TKA患者的ACB + IPACK。ACB + IPACK块的最小有效体积(MEV90)为17.99 mL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Orthopaedic Surgery
Journal of Orthopaedic Surgery ORTHOPEDICS-SURGERY
CiteScore
3.10
自引率
0.00%
发文量
91
审稿时长
13 weeks
期刊介绍: Journal of Orthopaedic Surgery is an open access peer-reviewed journal publishing original reviews and research articles on all aspects of orthopaedic surgery. It is the official journal of the Asia Pacific Orthopaedic Association. The journal welcomes and will publish materials of a diverse nature, from basic science research to clinical trials and surgical techniques. The journal encourages contributions from all parts of the world, but special emphasis is given to research of particular relevance to the Asia Pacific region.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信